IOL Chemicals and Pharmaceuticals Limited — Updates, 24-02-2026: General Updates
24-02-2026 | 05:40 pm
24-02-2026 | 05:40 pm
IOLCP secured a European CEP for CLOPIDOGREL BESILATE, expanding its API portfolio for cardiovascular drugs. This certification, adding to an existing CEP for CLOPIDOGREL BISULPHATE, strengthens market access for critical antiplatelet medication.
No comments yet. Be the first to comment!
All announcements from IOL Chemicals and Pharmaceuticals Limited
